Nemolizumab: a new key player in the treatment of prurigo nodularis

Br J Dermatol. 2024 Jul 16;191(2):154-155. doi: 10.1093/bjd/ljae189.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Humans
  • Prurigo* / drug therapy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized